These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20801762)

  • 1. Abnormal axial diffusivity in the deep gray nuclei and dorsal brain stem in infantile spasm treated with vigabatrin.
    Simao GN; Zarei Mahmoodabadi S; Snead OC; Go C; Widjaja E
    AJNR Am J Neuroradiol; 2011 Jan; 32(1):199-203. PubMed ID: 20801762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin-induced MRI changes associated with extrapyramidal symptoms in a child with infantile spasms.
    Schonstedt V; Stecher X; Venegas V; Silva C
    Neuroradiol J; 2015 Oct; 28(5):515-8. PubMed ID: 26306928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms.
    Dracopoulos A; Widjaja E; Raybaud C; Westall CA; Snead OC
    Epilepsia; 2010 Jul; 51(7):1297-304. PubMed ID: 20384718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vigabatrin administration in patients with infantile spasms: the risks.
    Jaseja H
    Clin Neurol Neurosurg; 2010 Nov; 112(9):835. PubMed ID: 20934097
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral MRI abnormalities associated with vigabatrin therapy.
    Pearl PL; Vezina LG; Saneto RP; McCarter R; Molloy-Wells E; Heffron A; Trzcinski S; McClintock WM; Conry JA; Elling NJ; Goodkin HP; de Menezes MS; Ferri R; Gilles E; Kadom N; Gaillard WD
    Epilepsia; 2009 Feb; 50(2):184-94. PubMed ID: 18783433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms.
    Fong CY; Osborne JP; Edwards SW; Hemingway C; Hancock E; Johnson AL; Kennedy CR; Kneen R; Likeman M; Lux AL; Mordekar SR; Murugan V; Newton RW; Pike M; Quinn M; Spinty S; Vassallo G; Verity CM; Whitney A; O'Callaghan FJ
    Dev Med Child Neurol; 2013 Sep; 55(9):862-7. PubMed ID: 23789722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible magnetic resonance imaging and spectroscopy abnormalities in the course of vigabatrin treatment for West syndrome.
    Thelle T; Gammelgaard L; Hansen JK; Østergaard JR
    Eur J Paediatr Neurol; 2011 May; 15(3):260-4. PubMed ID: 20926323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain MRI findings with vigabatrin therapy: case report and literature review.
    Hussain K; Walsh TJ; Chazen JL
    Clin Imaging; 2016; 40(1):180-2. PubMed ID: 26526789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin-associated brain abnormalities on MRI and other neurological symptoms in patients with West syndrome.
    Reyes Valenzuela G; Crespo A; Princich J; Fassulo L; Semprino M; Gallo A; Rugilo C; Pociecha J; Calvo A; Caraballo RH
    Epilepsy Behav; 2022 Apr; 129():108606. PubMed ID: 35180571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroids or vigabatrin in the treatment of infantile spasms?
    Riikonen RS
    Pediatr Neurol; 2000 Nov; 23(5):403-8. PubMed ID: 11118795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin therapy in infantile spasms: solving one problem and inducing another?
    Wohlrab G; Leiba H; Kästle R; Ramelli G; Schmitt-Mechelke T; Schmitt B; Landau K
    Epilepsia; 2009 Aug; 50(8):2006-8. PubMed ID: 19682036
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
    Ibrahim S; Gulab S; Ishaque S; Saleem T
    BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.
    Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R
    Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study.
    Ohtsuka Y
    Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
    Carmant L
    Acta Neurol Scand Suppl; 2011; (192):36-47. PubMed ID: 22061179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teaching NeuroImages: Reversible neuroimaging findings during treatment of infantile spasms with vigabatrin.
    Kim DD; Sharma AK; Sharma M; Andrade A
    Neurology; 2020 Oct; 95(16):e2314-e2315. PubMed ID: 32675075
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy of infantile spasms: new opportunities and emerging challenges.
    Mikati MA; Cornett KM
    Epilepsy Behav; 2010 Apr; 17(4):571-3. PubMed ID: 20097137
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of West syndrome with vigabatrin: reversible MRI signal changes.
    Carvalho Neto Ad; Coelho LO; Ono SE; Crippa AC
    Arq Neuropsiquiatr; 2011 Dec; 69(6):998. PubMed ID: 22297900
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
    Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
    Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.